Stress-induced cytokines and neuronal dysfunction in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 28, Issue 1, 2012, Pages 11-24

  Ricci, Serafino ^a   Fuso, Andrea ^a   Ippoliti, Flora ^a   Businaro, Rita ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alzheimer's disease; cytokines; HPA axis; lifestyle; neurogenesis; stress

Indexed keywords

ALPHA INTERFERON; C REACTIVE PROTEIN; CYTOKINE; FISH OIL; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 6; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM; DEPRESSION; DIET; DISEASE COURSE; ENCEPHALITIS; ENDOCRINE SYSTEM; ENVIRONMENTAL FACTOR; EXERCISE; GENETIC POLYMORPHISM; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INNATE IMMUNITY; LIFESTYLE; METABOLIC PARAMETERS; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; STRESS;

EID: 84855777698     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110821     Document Type: Review

References (129)

1. Fillit H, Hill J (2005) Economics of dementia and pharmacoeconomics of dementia therapy. Am J Geriatr Pharmacother 3, 39-49. (Pubitemid 41122357)
2. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M (2005) Alzheimers Disease International. Global prevalence of dementia: A Delphi consensus study. Lancet 366, 2112-2117. (Pubitemid 41797645)
3. Zhu CW, Sano M (2006) Economic considerations in the management of Alzheimers disease. Clin Interv Aging 1, 143-154.
4. Bermejo-Pareja F, Benito-Léon J, Vega S, Medrano MJ, Roḿan GC (2008) Neurological Disorders in Central Spain (NEDICES) Study Group. Incidence and subtypes of dementia in three elderly populations of central Spain. J Neurol Sci 264, 63-72. (Pubitemid 350193244)
5. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B (1997) Very old women at highest risk of dementia and Alzheimers disease: Incidence data from the Kungsholmen project, Stockholm. Neurology 48, 132-138. (Pubitemid 27039531)
6. Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA (2001) Is the risk of developing Alzheimers disease greater for women than for men? Am J Epidemiol 153, 132-136. (Pubitemid 32060603)
7. Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7, 137-152.
8. Wilson RS, Arnold SE, Schneider JA, Kelly JF, Tang Y, Bennett DA (2006) Chronic psychological distress and risk of Alzheimers disease in old age. Neuroepidemiology 27, 143-153. (Pubitemid 44651434)
9. Wilson RS, Krueger KR, Arnold SE, Schneider JA, Kelly JF, Barnes LL, Tang Y, Bennett DA (2007) Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry 64, 234-240. (Pubitemid 46220781)
10. Mej́a S, Giraldo M, Pineda D, Ardila A, Lopera F (2003) Nongenetic factors as modifiers of the age of onset of familial Alzheimers disease. Int Psychogeriatr 15, 337-349.
11. Chrousos GP (2009) Stress and disorders of the stress system. Nat Rev Endocrinol 5, 374-381.
12. McEwen BS (2007) Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiol Rev 87, 873-904. (Pubitemid 47086281)
13. Chrousos GP, Gold PW (1998) A healthy body in a healthy mind-and vice versa-the damaging power of "uncontrollable" stress. J Clin Endocrinol Metab 83, 1842-1845. (Pubitemid 28496303)
14. McEwen BS, Gianaros PJ (2010) Central role of the brain in stress and adaptation: Links to socioeconomic status, health, and disease. Ann N Y Acad Sci 1186, 190-222.
15. Munhoz CD, Garća-Bueno B, Madrigal JL, Lepsch LB, Scavone C, Leza JC (2008) Stress-induced neuroinflammation: Mechanisms and new pharmacological targets. Braz J Med Biol Res 41, 1037-1046.
16. Lucas SM, Rothwell NJ, Gibson RM (2006) The role of inflammation in CNS injury and disease. Br J Pharmacol 147(Suppl 1), S232-S240. (Pubitemid 43077281)
17. Elenkov IJ, Kvetnansky R, Hashiramoto A, Bakalov VK, Link AA, Zachman K, Crane M, Jezova D, Rovensky J, DimitrovMA, Gold PW, Bonini S, Fleisher T, Chrousos GP, Wilder RL (2008) Low-versus high-baseline epinephrine output shapes opposite innate cytokine profiles: Presence of Lewis-and Fischer-like neurohormonal immune phenotypes in humans? J Immunol 181, 1737-1745.
18. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES (2000) The sympathetic nerve-an integrative interface between two supersystems: The brain and the immune system. Pharmacol Rev 52, 595-638.
19. Szeĺenyi J, Vizi ES (2007) The catecholamine cytokine balance: Interaction between the brain and the immune system. Ann N Y Acad Sci 1113, 311-324. (Pubitemid 350015022)
20. Watkins LR, Maier SF, Goehler LE (1995) Cytokine-tobrain communication: A review & analysis of alternative mechanisms. Life Sci 57, 1011-1026.
21. BesedovskyH, Sorkin E, Keller M, Müller J (1975) Changes in blood hormone levels during the immune response. Proc Soc Exp Biol Med 150, 466-470.
22. Lundberg JM, Rudehill A, Sollevi A, Fried G, Wallin G (1989) Corelease of neuropeptide Y and noradrenaline from pig spleen in vivo: Importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport. Neuroscience 28, 475-486. (Pubitemid 19053088)
23. Bedoui S, Kawamura N, Straub RH, Pabst R, Yamamura T, von Hörsten S (2003) Relevance of neuropeptide Y for the neuroimmune crosstalk. J Neuroimmunol 134, 1-11. (Pubitemid 36050825)
24. Witt SH, BuchmannAF, Blomeyer D, NieratschkerV, Treutlein J, Esser G, Schmidt MH, Bidlingmaier M, Wiedemann K, Rietschel M, Laucht M, Wüst S, Zimmermann US (2011) An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses. Psychoneuroendocrinology 36, 1010-1020.
25. Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65, 732-741.
26. Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D, Ferstl R, von Eynatten M, Wendt T, Rudofsky G, Joswig M, Morcos M, Schwaninger M, McEwen B, Kirschbaum C, Nawroth PP (2003) A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci U S A 100, 1920-1925. (Pubitemid 36254549)
27. Garća-Bueno B, Madrigal JL, Ṕerez-Nievas BG, Leza JC (2008) Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats. Endocrinology 149, 1969-1978.
28. Johnson JD, Campisi J, Sharkey CM, Kennedy SL, Nickerson M, Greenwood BN, FleshnerM(2005) Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 135, 1295-1307. (Pubitemid 41416690)
29. Elenkov IJ (2008) Neurohormonal-cytokine interactions: Implications for inflammation, common human diseases and well-being. Neurochem Int 52, 40-51. (Pubitemid 350235704)
30. Leonard BE, Myint A (2009) The psychoneuroimmunology of depression. HumPsychopharmacol 24, 165-175.
31. Bossù P, Ciaramella A, Moro ML, Bellincampi L, Bernardini S, Federici G, Trequattrini A, Macciardi F, Spoletini I, Di Iulio F, Caltagirone C, Spalletta G (2007) Interleukin gene polymorphisms predict risk and outcome of Alzheimers disease. J Neurol Neurosurg Psychiatry 78, 807-811.
32. Yu JT, Tan L, Song JH, Sun YP, Chen W, Miao D, Tian Y (2009) Interleukin-18 promoter polymorphisms and risk of late onset Alzheimers disease. Brain Res 1253, 169-175.
33. Chapuis J, Hot D, Hansmannel F, Kerdraon O, Ferreira S, Hubans C, Maurage CA, Huot L, Bensemain F, Laumet G, Ayral AM, Fievet N, Hauw JJ, DeKosky ST, Lemoine Y, Iwatsubo T, Wavrant-Devrièze F, Dartigues JF, Tzourio C, Búee L, Pasquier F, Berr C, Mann D, Lendon C, Alṕerovitch A, Kamboh MI, Amouyel P, Lambert JC (2009) Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimers disease. Mol Psychiatry 14, 1004-1016.
34. de Kloet ER (2008) About stress hormones and resilience to psychopathology. J Neuroendocrinol 20, 885-892. (Pubitemid 351858742)
35. Dallman MF, Akana SF, Bhatnagar S, Bell ME, Choi S, Chu A, Horsley C, Levin N, Meijer O, Soriano LR, Strack AM, Viau V (1999) Starvation: Early signals, sensors, and sequelae. Endocrinology 140, 4015-4023. (Pubitemid 30647096)
36. Elenkov IJ, Chrousos GP (2002) Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 966, 290-303. (Pubitemid 34729188)
37. McEwen BS, Weiss JM, Schwartz LS (1968) Selective retention of corticosterone by limbic structures in rat brain. Nature 220, 911-912.
38. Sorrells SF, Sapolsky RM (2007) An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun 21, 259-272. (Pubitemid 46199119)
39. Garcia-Bueno B, Caso JR, Leza JC (2008) Stress as a neuroinflammatory condition in brain: Damaging and protective mechanisms. Neurosci Biobehav Rev 32, 1136-1151.
40. Sorrells SF, Caso JR, Munhoz CD, Sapolsky RM (2009) The stressed CNS: When glucocorticoids aggravate inflammation. Neuron 64, 33-39.
41. Yau JL, Noble J, Seckl JR (2011) 11{beta}-hydroxysteroid dehydrogenase type 1 deficiency prevents memory deficits with aging by switching from glucocorticoid receptor to mineralocorticoid receptor-mediated cognitive control. J Neurosci 31, 4188-4193.
42. Cottrell EC, Seckl JR (2009) Prenatal stress, glucocorticoids and the programming of adult disease. Front Behav Neurosci 3, 19.
43. Craft TK, Devries AC (2009) Vulnerability to stroke: Implications of perinatal programming of the hypothalamicpituitary-adrenal axis. Front Behav Neurosci 3, 54.
44. Levitt NS, Lindsay RS, Holmes MC, Seckl JR (1996) Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 64, 412-418. (Pubitemid 27007194)
45. Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerlaFM(2006) Glucocorticoids increase amyloid-β and tau pathology in a mouse model of Alzheimers disease. J Neurosci 26, 9047-9056. (Pubitemid 44319396)
46. Yoneyama M, Shiba T, Hasebe S, Ogita K (2011) Adult neurogenesis is regulated by endogenous factors produced during neurodegeneration. J Pharmacol Sci 115, 425-432.
47. Frinchi M, Di Liberto V, Olivieri M, Fuxe K, Belluardo N, Mudò G (2010) FGF-2/FGFR1 neurotrophic system expression level and its basal activation do not account for the age-dependent decline of precursor cell proliferation in the subventricular zone of rat brain. Brain Res 1358, 39-45.
48. Ricobaraza A, Cuadrado-Tejedor M, Marco S, Ṕerez-Otãno I, Garća-Osta A (2010) Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease. Hippocampus, doi:10.1002/hipo.20883.
49. Sousa N, Lukoyanov NV, Madeira MD, Almeida OF, Paula-Barbosa MM (2000) Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 97, 253-266. (Pubitemid 30224763)
50. McKittrick CR, Magarĩnos AM, Blanchard DC, Blanchard RJ, McEwen BS, Sakai RR (2000) Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin transporter sites. Synapse 36, 85-94. (Pubitemid 30196684)
51. Selkoe DJ (2002) Alzheimers disease is a synaptic failure. Science 298, 789-791.
52. Scheff SW, Price DA (2006) Alzheimers disease-related alterations in synaptic density: Neocortex and hippocampus. J Alzheimers Dis 9, 101-115. (Pubitemid 44253303)
53. Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ (2007) Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68, 1501-1508. (Pubitemid 46685921)
54. Conrad CD (2006) What is the functional significance of chronic stress-induced CA3 dendritic retraction within the hippocampus? Behav Cogn Neurosci Rev 5, 41-60. (Pubitemid 43987740)
55. Tata DA, Anderson BJ (2010) The effects of chronic glucocorticoid exposure on dendritic length, synapse numbers and glial volume in animal models: Implications for hippocampal volume reductions in depression. Physiol Behav 99, 186-193.
56. McEwen BS (2000) Effects of adverse experiences for brain structure and function. Biol Psychiatry 48, 721-731.
57. Demars M, Hu YS, Gadadhar A, LazarovO(2010) Impaired neurogenesis is an early event in the etiology of familial Alzheimers disease in transgenic mice. J Neurosci Res 88, 2103-2117.
58. SekiT, AraiY(1995) Age-related production of newgranule cells in the adult dentate gyrus. Neuroreport 6, 2479-2482. (Pubitemid 26031190)
59. Kempermann G, Kuhn HG, Gage FH (1998) Experienceinduced neurogenesis in the senescent dentate gyrus. J Neurosci 18, 3206-3912.
60. Kempermann G (2002) Why new neurons? Possible functions for adult hippocampal neurogenesis. J Neurosci 22, 635-638. (Pubitemid 34141743)
61. Taupin P (2009) Adult neurogenesis, neural stem cells and Alzheimers disease: Developments, limitations, problems and promises. Curr Alzheimer Res 6, 461-470.
62. Yang Y, Geldmacher DS, Herrup K (2001) DNA replication precedes neuronal cell death in Alzheimers disease. J Neurosci 21, 2661-2668. (Pubitemid 32298208)
63. Busser J, Geldmacher DS, Herrup K (1998) Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimers disease brain. J Neurosci 18, 2801-2807. (Pubitemid 28163210)
64. Taupin P (2011) Neurogenesis, NSCs, pathogenesis and therapies for Alzheimers disease. Front Biosci (Schol Ed) 3, 178-190.
65. Whitney NP, Eidem TM, Peng H, Huang Y, Zheng JC (2009) Inflammation mediates varying effects in neurogenesis: Relevance to the pathogenesis of brain injury and neurodegenerative disorders. J Neurochem 108, 1343-1359.
66. Taupin P (2005) Consideration of adult neurogenesis from basic science to therapy. Med Sci Monit 11, LE16-LE17. (Pubitemid 41482751)
67. Martino G, Pluchino S (2006) The therapeutic potential of neural stem cells. Nat Rev Neurosci 7, 395-406.
68. Zhao Z, Taylor WD, Styner M, Steffens DC, Krishnan KR, MacFall JR (2008) Hippocampus shape analysis and latelife depression. PLoS One 3, e1837.
69. Krugers HJ, Lucassen PJ, Karst H, Jöels M (2010) Chronic stress effects on hippocampal structure and synaptic function: Relevance for depression and normalization by anti-glucocorticoid treatment. Front Synaptic Neurosci 12, 2-24.
70. Oomen CA, Mayer JL, de Kloet ER, Jöels M, Lucassen PJ (2007) Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the reduction in neurogenesis after chronic stress. Eur J Neurosci 26, 3395-3401. (Pubitemid 350243543)
71. Leuner B, Gould E (2010) Structural plasticity and hippocampal function. Annu Rev Psychol 61, 111-140.
72. Lucassen PJ, Meerlo P, Naylor AS, van Dam AM, Dayer AG, Fuchs E, Oomen CA, Cźeh B (2010) Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant action. Eur Neuropsychopharmacol 20, 1-17.
73. Schloesser RJ, Manji HK, Martinowich K (2009) Suppression of adult neurogenesis leads to an increased hypothalamo-pituitary-adrenal axis response. Neuroreport 20, 553-557.
74. Loftis JM, Huckans M, Morasco BJ (2010) Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies. Neurobiol Dis 37, 519-533.
75. Samuels BA, Hen R (2011) Neurogenesis and affective disorders. Eur J Neurosci 33, 1152-1159.
76. Leonard BE (2007) Inflammation, depression and dementia: Are they connected? Neurochem Res 32, 1749-1756. (Pubitemid 47428863)
77. Cameron B, Landreth GE (2010) Inflammation, microglia, and Alzheimers disease. Neurobiol Dis 37, 503-509.
78. Majde JA (2010) Neuroinflammation resulting from covert brain invasion by common viruses -a potential role in local and global neurodegeneration. Med Hypotheses 75, 204-213.
79. Yirmiya R, Goshen I (2011) Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 25, 181-213.
80. Spooren A, Kolmus K, Laureys G, Clinckers R, De Keyser J, Haegeman G, Gerlo S (2011) Interleukin-6, a mental cytokine. Brain Res Rev 67, 157-183.
81. Swardfager W, Lanctôt K, Rothenburg L, Wong A, Cappell J, Herrmann N (2010) A meta-analysis of cytokines in Alzheimers disease. Biol Psychiatry 68, 930-941.
82. McAfoose J, Baune BT (2009) Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 33, 355-366.
83. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhj P, Pedersen BK (1999) A high plasma concentration of TNF-β is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 54, M357-M364. (Pubitemid 129785358)
84. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhj P, Pedersen BK (1999) A high plasma concentration of TNF-β is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 54, M357-M364. (Pubitemid 129785358)
85. Maes M (2001) Interleukin-1β and the etiology of depression. Acta Psychiatr Scand 103, 161-162.
86. Bob P, Raboch J, Maes M, Susta M, Pavlat J, Jasova D, Vevera J, Uhrova J, BenakovaH, Zima T (2010) Depression, traumatic stress and interleukin-6. J Affect Disord 120, 231-234.
87. Miller GE, Rohleder N, Cole SW (2009) Chronic interpersonal stress predicts activation of pro-and anti-inflammatory signaling pathways 6 months later. Psychosom Med 71, 57-62.
88. Tran TT, Srivareerat M, Alkadhi KA (2010) Chronic psychosocial stress triggers cognitive impairment in a novel at-risk model of Alzheimers disease. Neurobiol Dis 37, 756-763.
89. Vitkovic L, Bockaert J, Jacque C (2000) "Inflammatory" cytokines: Neuromodulators in normal brain? J Neurochem 74, 457-471. (Pubitemid 30053717)
90. Krueger JM, Ob́al FJ, Fang J, Kubota T, Taishi P (2001) The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci 933, 211-221. (Pubitemid 32386036)
91. Krueger JM, Majde JA, Rector DM (2011) Cytokines in immune function and sleep regulation. Handb Clin Neurol 98, 229-240.
92. Opp MR (2005) Cytokines and sleep. Sleep Med Rev 9, 355-364. (Pubitemid 41243212)
93. Wolf G, Yirmiya R, Goshen I, Iverfeldt K, Holmlund L, Takeda K, Shavit Y (2003) Impairment of interleukin-1 (IL-1) signaling reduces basal pain sensitivity in mice: Genetic, pharmacological and developmental aspects. Pain 104, 471-480. (Pubitemid 37289046)
94. Goshen I, Yirmiya R (2009) Interleukin-1 (IL-1): A central regulator of stress responses. Front Neuroendocrinol 30, 30-45.
95. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, OBanion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimers disease. Neurobiol Aging 21, 383-421.
96. Shaftel SS, Griffin WS, OBanion MK (2008) The role of interleukin-1 in neuroinflammation and Alzheimer disease: An evolving perspective. J Neuroinflammation 26, 5-7.
97. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JC, Breteler MM (2004) Inflammatory proteins in plasma and the risk of dementia: The rotterdam study. Arch Neurol 61, 668-672. (Pubitemid 38637682)
98. Tan ZS, Beiser AS, Vasan RS, Roubenoff R, Dinarello CA, Harris TB, Benjamin EJ, Au R, Kiel DP, Wolf PA, Seshadri S (2007) Inflammatory markers and the risk of Alzheimer disease: The Framingham Study. Neurology 68, 1902-1908. (Pubitemid 46848622)
99. Ross RL, Jones KD, Bennett RM, Ward RL, Druker BJ, Wood LJ (2010) Preliminary evidence of increased pain and elevated cytokines in fibromyalgia patients with defective growth hormone response to exercise. Open Immunol J 3, 9-18.
100. Khairova RA, Machado-Vieira R, Du J, Manji HK (2009) A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 12, 561-578.
101. Gould E, Reeves AJ, Graziano MS, Gross CG (1999) Neurogenesis in the neocortex of adult primates. Science 286, 548-552.
102. Gould E, Tanapat P (1999) Stress and hippocampal neurogenesis. Biol Psychiatry 46, 1472-1479.
103. Gonzalez-Perez O, Jauregui-Huerta F, Galvez-ContrerasAY (2010) Immune system modulates the function of adult neural stem cells. Curr Immunol Rev 6, 167-173.
104. Russo I, Barlati S, Bosetti F (2011) Effects of neuroinflammation on the regenerative capacity of brain stem cells. J Neurochem 116, 947-956.
105. Morrison CD (2009) Leptin signaling in brain: A link between nutrition and cognition? Biochim Biophys Acta 1792, 401-408.
106. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM (1996) Leptin enters the brain by a saturable system independent of insulin. Peptides 17, 305-311. (Pubitemid 26124406)
107. Morales I, Faŕas G, Maccioni RB (2010) Neuroimmunomodulation in the pathogenesis of Alzheimers disease. Neuroimmunomodulation 17, 202-204.
108. Rozemuller AJ, van Gool WA, Eikelenboom P (2005) The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimers disease: Therapeutic implications. Curr Drug Targets CNS Neurol Disord 4, 223-233. (Pubitemid 40754159)
109. GrayWP(2008) NeuropeptideYsignalling on hippocampal stem cells in health and disease. Mol Cell Endocrinol 288, 52-62.
110. Benarroch EE (2009) NeuropeptideY: Its multiple effects in the CNS and potential clinical significance. Neurology 72, 1016-1020.
111. Besedovsky HO, Rey AD (2007) Physiology of psychoneuroimmunology: A personal view. Brain Behav Immun 21, 34-44. (Pubitemid 44854450)
112. Besedovsky HO, del Rey A (2011) Central and peripheral cytokines mediate immune-brain connectivity. Neurochem Res 36, 1-6.
113. Sapolsky RM, Krey LC, McEwen BS (1986) The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocr Rev 7, 284-301.
114. Lehnardt S (2010) Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll-like receptormediated neuronal injury. Glia 58, 253-263.
115. Buchanan MM, Hutchinson M, Watkins LR, Yin H (2010) Toll-like receptor 4 in CNS pathologies. J Neurochem 114, 13-27.
116. Black PH (2006) The inflammatory consequences of psychologic stress: Relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypotheses 67, 879-891. (Pubitemid 44062125)
117. Abe K, Kuo L, Zukowska Z (2010) Neuropeptide Y is a mediator of chronic vascular and metabolic maladaptations to stress and hypernutrition. Exp Biol Med (Maywood) 235, 1179-1184.
118. Kennedy A, Martinez K, Chuang CC, LaPoint K, McIntosh M (2009) Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: Mechanisms of action and implications. J Nutr 139, 1-4.
119. Luchsinger JA, Gustafson DR (2009) Adiposity, type 2 diabetes, and Alzheimers disease. J Alzheimers Dis 16, 693-704.
120. Morley JE, Banks WA (2010) Lipids and cognition. J Alzheimers Dis 20, 737-747.
121. Pistell PJ, Morrison CD, Gupta S, Knight AG, Keller JN, Ingram DK, Bruce-Keller AJ (2010) Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol 219, 25-32.
122. Kapogiannis D, Mattson MP (2011) Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimers disease. Lancet Neurol 10, 187-198.
123. Bruce-Keller AJ, Keller JN, Morrison CD (2009) Obesity and vulnerability of the CNS. Biochim Biophys Acta 1792, 395-400.
124. Panza F, Frisardi V, Seripa D, Pilotto A, Solfrizzi V (2010) Plasma levels of n-3 polyunsaturated fatty acids and cognitive decline: Possible role of depressive symptoms and apolipoprotein E genotyping. J Am Geriatr Soc 58, 2249-2251.
125. Ǵomez-Pinilla F (2008) Brain foods: The effects of nutrients on brain function. Nat Rev Neurosci 9, 568-578. (Pubitemid 351873468)
126. Spencer JP (2008) Food for thought: The role of dietary flavonoids in enhancing human memory, learning and neurocognitive performance. Proc Nutr Soc 67, 238-252. (Pubitemid 351543406)
127. van Praag H (2009) Exercise and the brain: Something to chew on. Trends Neurosci 32, 283-290.
128. Radak Z, Hart N, Sarga L, Koltai E, Atalay M, Ohno H, Boldogh I (2010) Exercise plays a preventive role against Alzheimers disease. J Alzheimers Dis 20, 777-783.
129. Bragin V, Chemodanova M, Dzhafarova N, Bragin I, Czerniawski JL, Aliev G (2005) Integrated treatment approach improves cognitive function in demented and clinically depressed patients. Am J Alzheimers Dis Other Demen 20, 21-26. (Pubitemid 40224057)